[1]刘晓玲,孙振国,胡冰.JPKD软件在颅脑术后肾功能亢进病人万古霉素应用中的指导价值[J].中国临床神经外科杂志,2022,27(12):974-976.[doi:10.13798/j.issn.1009-153X.2022.12.005]
　LIU Xiao-ling,SUN Zhen-guo,HU Bing.Application of JPKD software to vancomycin treatment for patients with suspected intracranial infection associated with augmented renal clearance secondary to craniotomy[J].,2022,27(12):974-976.[doi:10.13798/j.issn.1009-153X.2022.12.005]
点击复制

JPKD软件在颅脑术后肾功能亢进病人万古霉素应用中的指导价值()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年12期
页码:
974-976
栏目:
论著
出版日期:
2022-12-31

文章信息/Info

Title:
Application of JPKD software to vancomycin treatment for patients with suspected intracranial infection associated with augmented renal clearance secondary to craniotomy
文章编号:
1009-153X（2022）12-0974-03
作者:
刘晓玲; 孙振国; 胡冰
221009江苏，徐州市中心医院药学部（刘晓玲、胡冰），神经外科（孙振国）
Author(s):
LIU Xiao-ling1;  SUN Zhen-guo2;  HU Bing1
1. Department of Pharmacy, Xuzhou Central Hospital, Xuzhou 221009, China; 2. Department of Neurosurgery, Xuzhou Central Hospital, Xuzhou 221009, China
关键词:
颅脑手术; 肾功能亢进; 万古霉素; JPKD软件; 血药浓度
Keywords:
Craniotomy;  Vancomycin;  JPKD software;  Augmented renal clearance;  Blood drug concentration
分类号:
R651
DOI:
10.13798/j.issn.1009-153X.2022.12.005
文献标志码:
A
摘要:
目的 探讨JPKD群体药代动力学软件在颅脑术后肾功能亢进病人中的应用价值。方法 2021年1月至2022年1月前瞻性收治12例颅脑术后怀疑颅内感染且肾功能亢进病人，常规剂量（1 g，12 h/次）万古霉素治疗48 h，测定血药谷浓度，如果血药谷浓度<10 mg/L，则应用JPKD软件调整用药。结果 调整前，12例万古霉素稳态血药谷浓度<10 mg/L，根据JPKD软件调整用药，1例调整为利奈唑胺；其余11例调整后万古霉素稳态血药谷浓度为（15.93±1.30）mg/L。JPKD软件预估血药浓度为（14.12±2.13）mg/L，WRES值为14.49%，预测价值良好。JPKD软件调整给药后，8例治疗有效，1例治疗无效，1例应用万古霉素12 d病情平稳时转至当地医院治疗，1例因广泛耐药鲍曼不动杆菌感染停用万古霉素而改为多粘菌素B治疗。结论 常规剂量万古霉素（1 g，12 h/次）不适用颅脑术后肾功能亢进病人，JPKD软件可较好地协助调整万古霉素给药方案。
Abstract:
Objective To explore the application value of JPKD software to vancomycin treatment for patients with suspected intracranial infection associated with augmented renal clearance (ARC) secondary to craniotomy. Methods Twelve patients with suspected intracranial infection associated with ARC secondary to craniotomy were prospectively selected. The serum minimum concentration of vancomycin was determined 48 h after the use of vancomycin treatment with a conventional dose (1 g, 12 h/time). If the serum minimum concentration was less than 10 mg/L, JPKD software was used to adjust the medication of vancomycin. Results Before adjustment, the serum minimum concentration of vancomycin was less than 10 mg/L in all the patients. One patient was adjusted to linezolid according to JPKD software. The concentration of vancomycin was (15.93±1.30) mg/L in the other 11 patients, whose serum concentration was (14.12±2.13) mg/L predicted by JPKD software, and the WRES value was 14.49% which showed good predictive value. Of 11 patients treated with vancomycin, 8 patients were cured, 1 was ineffective, 1 was transferred to a local hospital after vancomycin treatment for 12 days with a stable condition, and 1 was treated with polymyxin B instead of vancomycin due to extensively drug-resistant Acinetobacter baumannii infection. Conclusions The routine dose of vancomycin (1 g, 12 h/ time) is not suitable for patients with suspected intracranial infection associated with ARC secondary to craniotomy hyperrenal function after cranial. JPKD software can help to adjust the administration of vancomycin.

参考文献/References:

[1]丁楠楠，洪学军. 重症患者肾功能亢进现象及药物剂量调整的研究进展[J]. 中国医院药学杂志，2019，39（7）：762-766.
[2]Cook AM, Hatton-Kolpek J. Augmented renal clearance [J]. Pharmacotherapy, 2019, 39(3): 346-354.
[3]王　宁，曲　鑫，周建新. 神经外科中枢神经系统感染诊治中国专家共识（2021版）[J]. 中华神经外科杂志，2021，37（1）：2-15.
[4]何　娟，杨婉花. 基于群体药动学的万古霉素个体化给药模式的建立和临床应用[J]. 中国临床药学杂志，2015，24（1）：27-31.
[5]张树永，王晓明，刘家云，等. 2018-2020年多中心脑脊液分离菌分布及耐药性分析[J]. 中国抗生素杂志，2021，46（11）：994-1001.
[6]尹立山，刘佰运，缪国专，等. 大剂量万古霉素治疗颅脑术后颅内感染的疗效[J]. 中国临床神经外科杂志，2018，23（5）：352-353.
[7]Beach JE, Perrott J, Turgeon RD, et al. Penetration of van-comycin into the cerebrospinal fluid: a systematic review [J]. Clin Pharmacokinet, 2017, 56(12): 1479-1490.
[8]李庆岗，程　岗，张剑宁. 血药浓度监测在万古霉素治疗MRSA颅内感染中的价值[J]. 中国临床神经外科杂志，2021，26（4）：243-249.
[9]Nelson NR, Morbitzer KA, Jordan JD, et al. The impact of capping creatinine clearance on achieving therapeutic van-comycin concentrations in neurocritically ill patients with traumatic brain injury [J]. Neurocrit Care, 2019, 30(1): 126-131.
[10]李小婷，毛　璐. 临床药师参与1例肾功能亢进患者抗感染治疗的药学实践[J]. 中国药物应用与监测，2021，18（5）：308-310.

相似文献/References:

[1]李瑞春　李　扩　鲍　刚　廉民学　祁　磊　谢万福　徐高峰.建立侧颅底表面坐标系定位乙状窦-横窦交汇区的解剖与临床研究[J].中国临床神经外科杂志,2015,(11):677.[doi:10.13798/j.issn.1009-153X.2015.11.022]
　LI Rui-chun,LI Kuo,Bao Gang,et al.Anatomic and clinical study of localization of the transverse-sigmoid sinus junction using a coordinate system on the lateral surface of the cranial base[J].,2015,(12):677.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[2]常洪波　潘腾飞　高　铭　卢旺盛　崔　凯　王　鹏　张剑宁.犬移植生物型硬脑膜补片实验研究[J].中国临床神经外科杂志,2016,(05):317.[doi:10.13798/j.issn.1009-153X.2016.05.022]
[3]刘华明　黄书岚.血小板凝胶在颅脑手术中的临床应用[J].中国临床神经外科杂志,2016,(03):152.[doi:10.13798/j.issn.1009-153X.2016.03.007]
　LIU Hua-ming,HUANG Shu-lan..Clinical application of platelet gel to neurosurgery[J].,2016,(12):152.[doi:10.13798/j.issn.1009-153X.2016.03.007]
[4]陈　俊　周赤忠　付　伟　潘德锐.开颅术后继发性颅内感染致脑梗死15例分析[J].中国临床神经外科杂志,2016,(01):40.[doi:10.13798/j.issn.1009-153X.2016.01.014]
[5]栗志弘,康凯,赵德强.数字三维重建影像在神经外科手术规划中的应用[J].中国临床神经外科杂志,2017,(02):118.[doi:10.13798/j.issn.1009-153X.2017.02.021]
[6]李良芳　王林甫　金彩辉　黄俊杰.扩大皮瓣在开颅手术中的应用[J].中国临床神经外科杂志,2017,(03):176.[doi:10.13798/j.issn.1009-153X.2017.03.017]
[7]袁　波　邢海涛　应建有　娄志刚　段勇刚　谭占国.鲍曼不动杆菌致颅内感染的临床特点及救治体会（附7例报道）[J].中国临床神经外科杂志,2017,(04):252.[doi:10.13798/j.issn.1009-153X.2017.04.017]
[8]李春坡　郑　军　边　涛　李海元　韩安国.局部封闭治疗颅脑手术后枕大神经痛[J].中国临床神经外科杂志,2017,(05):350.[doi:10.13798/j.issn.1009-153X.2017.05.025]
[9]刘荣华　段奎甲.颅脑术后颅内感染相关危险因素分析[J].中国临床神经外科杂志,2017,(06):407.[doi:10.13798/j.issn.1009-153X.2017.06.014]
　LIU Rong-hua,DUAN Kui-jia..Risk factors related to intracranial infection after craniotomy[J].,2017,(12):407.[doi:10.13798/j.issn.1009-153X.2017.06.014]
[10]龚金兵　喻坚柏　罗　刚　张占伟　李春辉.硬脑膜补丁修补法在预防术后脑脊液漏中的作用[J].中国临床神经外科杂志,2018,(03):200.[doi:10.13798/j.issn.1009-153X.2018.03.021]

备注/Memo

备注/Memo:
（2022-05-25收稿，2022-08-29修回）
基金项目：江苏省医院学会-精益化用药-石药专项基金（JY202037）
通讯作者：胡　冰，E-mail：hubing1020_163.com
更新日期/Last Update: 2022-01-31